Complex regional pain syndrome (CRPS) has been reported and studied in adults for many years. It is a less acknowledged disorder in children, probably due to underdiagnosis. The presentation and ...
BRC-002 is an oral botanically-derived cannabinoid agent expected to reduce the pain and comorbidities associated with CRPS. The FDA has granted Orphan Drug designation to BRC-002 (cannabidiol ...
Note: criteria 2,3, and 4 are necessary for a diagnosis of complex regional pain syndrome (1 is not always present). The presence of continuing pain, allodynia, or hyperalgesia after a nerve ...